ghk cu clinical trials results january 2026 Biological efficacy of GHK-Cu after ionic-liquid loading. (a) Cellular The potential of GHK as – Squalane + Copper Peptide Rapid

The risk factors that put you in the highest-danger category include longer diabetes duration (Charcot risk typically peaks after 7+ years), poor glycemic control, obesity the single most significant modifiable risk factor and a prior Charcot episode in the other foot, since roughly 25% of cases eventually become bilateral

That is a striking endorsement from one of the worlds most respected genomics research institutions

Its uniquely stable peptide-copper structure heavily supports ongoing exploration into cellular repair, anti-aging signaling, and tissue adaptation mechanisms

Mitra, M

Unlike receptor-specific agonists, DSIP is investigated for its broader neuro-modulatory profile and interactions within hypothalamicpituitary signaling networks, making it of interest in sleep and endocrine research models